Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.
Canopy Growth's Capital Expenditure for the
three
months ended in Dec. 2023 was $-0.36 Mil. Its Operating Income for the
three
months ended in Dec. 2023 was $-18.58 Mil.
GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.
Canopy Growth Capex-to-Operating-Income Historical Data
The historical data trend for Canopy Growth's Capex-to-Operating-Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Canopy Growth's Capex-to-Operating-Income
For the Drug Manufacturers - Specialty & Generic subindustry, Canopy Growth's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Canopy Growth's Capex-to-Operating-Income Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Canopy Growth's Capex-to-Operating-Income distribution charts can be found below:
* The bar in red indicates where Canopy Growth's Capex-to-Operating-Income falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.
Canopy Growth Capex-to-Operating-Income Related Terms
Thank you for viewing the detailed overview of Canopy Growth's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Canopy Growth (Canopy Growth) Business Description
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Doja, 7ACRES, Tweed, and Deep Space. Its non-THC products include sports drink BioSteel, skincare products under This Works, Martha Stewart CBD, and Storz & Bickel vaporizers. Canopy growth is attempting to merge its U.S. assets into a separately operated holding company, Canopy USA, which will not be consolidated into the Canadian company's financials.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CGC has been successfully added to your 